유나이티드 테라퓨틱스 (UTHR)

04:34 AM

[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan

04:34 AM

Jul 10, 2026

United Therapeutics director Jan Malcolm sells $178,941 in stock - Investing.com UK

Jul 10, 2026

Jul 10, 2026

United Therapeutics director Jan Malcolm sells $178,941 in stock By Investing.com - Investing.com Australia

Jul 10, 2026

Jul 10, 2026

Insider Sell: Jan Malcolm Sells Shares of United Therapeutics Co - GuruFocus

Jul 10, 2026

Jul 10, 2026

Form 4 United Therapeutics Corporation For: 10 July By Investing.com - Investing.com South Africa

Jul 10, 2026

Jul 10, 2026

UTHR Stock Quote Price and Forecast - CNN

Jul 10, 2026

Jul 10, 2026

United Therapeutics CEO Martine Rothblatt sells $5.2m shares By Investing.com - Investing.com Australia

Jul 10, 2026

Jul 09, 2026

Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.25m By Investing.com - Investing.com Australia

Jul 09, 2026

Jul 09, 2026

United Therapeutics CEO Martine Rothblatt sells $5.2m shares - Investing.com

Jul 09, 2026

Jul 09, 2026

Martine Rothblatt, United Therapeutics chairperson & CEO, sells $5.25m - Investing.com

Jul 09, 2026

Jul 09, 2026

Form 4 United Therapeutics Corporation For: 9 July By Investing.com - Investing.com Canada

Jul 09, 2026

Jul 09, 2026

United Therapeutics Stock Rises 14% YTD: Here's What You Need to Know - TradingView

Jul 09, 2026

Jul 09, 2026

United Therapeutics: CEO's Multi-Million Dollar Sales Signal Caution Amidst Bullish Consensus - Kavout | AI

Jul 09, 2026

Jul 08, 2026

United Therapeutics CEO Martine Rothblatt sells $5.3m company stock - Investing.com

Jul 08, 2026

Jul 08, 2026

Form 4 United Therapeutics Corporation For: 8 July By Investing.com - Investing.com South Africa

Jul 08, 2026

Jul 08, 2026

United Therapeutics CEO Martine Rothblatt sells $5.3m company stock By Investing.com - Investing.com Nigeria

Jul 08, 2026

Jul 08, 2026

Is United Therapeutics Corporation (UTHR) Stock a Long-Term Opportunity in Organ Transplant Innovation? - Insider Monkey

Jul 08, 2026

Jul 08, 2026

United Therapeutics expands immune therapy pipeline with Thymmune - BioBuzz

Jul 08, 2026

Jul 08, 2026

United Therapeutics focuses on pulmonary arterial hypertension. Nasdaq-listed biotech builds on its - Ad-hoc-news.de

Jul 08, 2026

Jul 07, 2026

United Therapeutics Corp (UTHR) Stock Up 3.0% but GF Value Says Overvalued -- GF Score: 88/100 - GuruFocus

Jul 07, 2026

Jul 07, 2026

United Therapeutics CEO Rothblatt sells $5.2m in company stock By Investing.com - Investing.com South Africa

Jul 07, 2026

Jul 07, 2026

Form 4 United Therapeutics Corporation For: 7 July By Investing.com - Investing.com Nigeria

Jul 07, 2026

Jul 07, 2026

United Therapeutics CEO Rothblatt sells $5.2m in company stock - Investing.com

Jul 07, 2026

Jul 06, 2026

United Therapeutics: Trifecta Of 2026 Tyvaso Franchise Filings Makes It A Compelling Buy - Seeking Alpha

Jul 06, 2026

Jul 06, 2026

United Therapeutics Vs. Regencell Bioscience: I Choose Profits Over Promises (NASDAQ:RGC) - Seeking Alpha

Jul 06, 2026

Jul 06, 2026

RTP drugmaker strikes $300M deal for Massachusetts company - The Business Journals

Jul 06, 2026

Jul 05, 2026

United Therapeutics EVP Paul Mahon sells $4.87m in common stock - Investing.com

Jul 05, 2026

Jul 02, 2026

MannKind Stock Plummets After Partner United Therapeutics Unveils New ‘Category Killer Product’ - Stocktwits

Jul 02, 2026

Jul 02, 2026

United Therapeutics Buys Thymmune For Up To $300M - Law360

Jul 02, 2026

Jul 02, 2026

Thymmune Therapeutics acquired by Maryland biotech for $140M - The Business Journals

Jul 02, 2026

Jul 02, 2026

United Therapeutics buys Massachusetts biotech Thymmune Therapeutics for $140M - The Business Journals

Jul 02, 2026

Jul 02, 2026

United Therapeutics Expands Immune Therapy Pipeline With Thymmune - Benzinga

Jul 02, 2026

Jul 02, 2026

United Therapeutics (UTHR) Expands Portfolio with Thymmune Thera - GuruFocus

Jul 02, 2026

Jul 02, 2026

United Therapeutics (UTHR) Acquires Thymmune Therapeutics for $1 - GuruFocus

Jul 02, 2026

Jul 02, 2026

United Therapeutics Expands Regenerative Medicine Pipeline with $140M Thymmune Acquisition - citybiz

Jul 02, 2026

Jul 02, 2026

United Therapeutics buys Thymmune, adding thymus cell therapy platform - Stock Titan

Jul 02, 2026

Jul 01, 2026

The Oliver Patch Project Announces United Therapeutics Corporation Named Visionary/Presenting Sponsor of National Patch Day 2026 - Morningstar

Jul 01, 2026

Jun 30, 2026

United Therapeutics chairperson & CEO Rothblatt sells $5.18m stock - Investing.com UK

Jun 30, 2026

Jun 30, 2026

United Therapeutics chairperson & CEO Rothblatt sells $5.18m stock By Investing.com - Investing.com South Africa

Jun 30, 2026

Jun 30, 2026

Form 4 United Therapeutics Corporation For: 30 June By Investing.com - Investing.com Nigeria

Jun 30, 2026

Jun 30, 2026

FDA Approval Positions United Therapeutics To Broaden Access To Donor Lungs - Sahm

Jun 30, 2026

Jun 30, 2026

Big Pharma Has a Case of Merger Mania - The Motley Fool

Jun 30, 2026

Jun 29, 2026

United Therapeutics Corporation 8-K Filing Details: Stock Incentive Plan, Key Shareholder Info & SEC Compliance (June 2026) – Minichart - Minichart

Jun 29, 2026

Jun 29, 2026

FDA approves United Therapeutics’ LungFX lung perfusion device By Investing.com - Investing.com South Africa

Jun 29, 2026